Clinical Trials Logo

Clinical Trial Summary

Prospective, multicenter, randomized, placebo-controlled, double-blind clinical trial to evaluate safety and efficacy of candesartan in the prevention of the development of Dilated Cardiomyopathy (DCM) in genetic carriers of a DCM-causing variant without disease expression (asymptomatic)


Clinical Trial Description

Prospective, multicenter, randomized, placebo-controlled, double-blind clinical trial to evaluate safety and efficacy of early administration of candesartan in the prevention of the development of Dilated Cardiomyopathy (DCM) in genetic carriers of a DCM-causing variant without disease expression (asymptomatic). Randomization will be 1:1 and patients are allocated to candesartan or matching placebo. Patients will be followed for a 3 years period and efficacy will be demonstrated if candesartan (compared to placebo) prevents either a significant Left ventricular ejection fraction (LVEF) decline of ≥10%, or a ventricular dilatation (left ventricular end-diastolic volume, LVEDV) increase of ≥10% within a 3-years period of follow-up ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05321875
Study type Interventional
Source Puerta de Hierro University Hospital
Contact Cristina Avendaño-Solá, MD, PhD
Phone +34 91 1916479
Email cavendano@salud.madrid.org
Status Recruiting
Phase Phase 3
Start date June 2, 2022
Completion date June 2, 2026

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03560167 - Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation N/A
Terminated NCT00624520 - Mental Stress Reduction in Defibrillator Patients Phase 3
Completed NCT00549861 - Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR N/A
Terminated NCT04222101 - Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy N/A
Not yet recruiting NCT02517814 - Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy N/A
Completed NCT01391507 - Pilot Study of COR-1 in Heart Failure Phase 2
Completed NCT01940081 - The Leiden Nonischemic Cardiomyopathy Study
Completed NCT01181414 - Spanish Atrial Fibrillation And Resynchronization Study Phase 4
Not yet recruiting NCT06091475 - Therapy to Maintain Remission in Dilated Cardiomyopathy N/A
Recruiting NCT03340675 - Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Phase 2
Recruiting NCT05981092 - A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease)
Not yet recruiting NCT06039072 - Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
Recruiting NCT03910725 - Electrophysiological Phenotyping Of Patients at Risk of Ventricular Arrhythmia and Sudden Cardiac Death
Terminated NCT01478087 - Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM) N/A
Recruiting NCT00221780 - Role of Left Ventricular Pacing Site N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Completed NCT00123071 - Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network N/A
Completed NCT00284713 - Progenitor Cell Therapy in Dilative Cardiomyopathy Phase 1/Phase 2
Completed NCT01260402 - Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure. N/A
Completed NCT04192214 - The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor Phase 2